Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Omega Fund VI, L.P.'s stake in Lexeo Therapeutics, Inc. fell to 3.60% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Omega Fund VI, L.P.'s stake in Lexeo Therapeutics, Inc. fell to 3.60%, 1,184,636 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 3.60%
- Shares
- 1,184,636
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Omega Fund VI, L.P. | 3.60% | 1,184,636 |
| Omega Fund VI GP, L.P. | 3.60% | 1,184,636 |
| Omega Fund VI GP Manager, Ltd. | 3.60% | 1,184,636 |
| Claudio Nessi | 3.60% | 1,184,636 |
| Otello Stampacchia | 3.60% | 1,184,636 |
| Francesco Draetta | 3.60% | 1,184,636 |
Source
Related
- Lexeo Therapeutics, Inc.
- Omega Fund VI, L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026